HeyJaredState of Medtech
State of Medtech is the 1 podcast in medtech and medical devices. Hosted by Omar M. Khateeb, we go inside the business and science of healthcare innovation—with unfiltered interviews from top investors, startup founders, and industry leaders.
- Indexed episodes, last 90 days
- 22
- Latest publication
- Sep 23, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
417. Unlocking Capital for Medtech Through QSBS (opens the original)
Read excerpt
In this solo episode, Omar Khateeb explores why QSBS could become an overlooked capital formation tool in MedTech . QSBS was created to encourage investment in small American businesses, and Omar explains why it may fit MedTech investing well. Medical device companies often require years of engineering, clinical development, FDA review, reimbursement, manufacturing, and commercialization before investors see liquidity. Those timelines can put MedTech at a disadvantage against fast sectors. QSBS
416. Venture Capital: Aneta Sottil of Andera Partners on Building MedTech Companies Investors Can Scale (opens the original)
Read excerpt
In this episode, Omar Khateeb speaks with Aneta Sottil, Partner at Andera Partners, about what makes a MedTech company investable as the investment bar continues to rise. Aneta explains why early data is often no longer enough. Investors increasingly want stronger clinical validation, a clear path to market, reimbursement strategy, and proof that a technology can meaningfully improve patient care. She also explains the must-have vs nice-to-have test, why hardware matters, and why founder-investo
415. Urology Venture Capital: AUA Nexus with Gavin Leonard of MedTech Syndicates and Steven Kaplan MD of the American Urological Association (opens the original)
Read excerpt
Explore Showpad's VIP event, Excellence in the Field, in New York on October 8, 2026, for revenue leaders seeking practical AI and sales insights. Learn more . In this episode, Omar Khateeb speaks with Gavin Leonard, CEO of MedTech Syndicates, and Steven Kaplan, Director of the American Urological Association Innovation Nexus, to explore how clinical insight, capital and commercialization can move MedTech ideas toward patient impact. Steven shares how Nexus connects founders, clinicians, investo
414. Corporate Venture:Virginia Giddings of Edwards Lifesciences on the MedTech Innovation Journey (opens the original)
Read excerpt
In this episode, Omar Khateeb speaks with Virginia Giddings, Vice President of Exploration at Edwards Lifesciences , about how major MedTech companies evaluate startups before commercial scale. Virginia explains why Edwards builds early relationships in structural heart and heart failure, assessing patient need, clinical evidence, reimbursement, and strategic fit. She shares why founders need conviction, coachability, and candor, and how a relationship that began in 2015 grew into a heart failur
413. Cardiovascular Innovation at Scale: David Hochman of Orchestra BioMed on Medtronic, AVM Therapy and Strategic Partnerships (opens the original)
Read excerpt
In this episode, Omar Khateeb speaks with David Hochman, Chairman & CEO of Orchestra BioMed, about a partnership-driven model for building, funding, and commercializing MedTech innovation. Orchestra focuses on intellectual property, clinical development, and pivotal execution while partnering with global strategics that already have the infrastructure to manufacture, commercialize, and scale. Rather than building solely for acquisition, the company uses licensing and royalty structures to retain
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.